(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM COMPOSTO NA PREPARAÇÃO DE UM COMPRIMIDO PARA TRATAMENTO ORAL DE UM CÂNCER DEPENDENTE DE REPLICAÇÃO DE CDK4/6 EM UM HUMANO

Em ExigênciaInvention PatentPCT · US2019012720

Application data

Number

112020013915

Type

Invention Patent

Filing

01/08/2019

Publication

12/01/2020

PCT

US2019012720

Progress at the INPI

Technical opinion to answer
  1. Filing01/08/19
  2. Publication12/01/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/07/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

G1 THERAPEUTICS, INC.

US

Inventors

A. B. (pessoa física)

US

J. S. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/614,952 · 01/08/2018

US

62/679,575 · 06/01/2018

US

62/788,017 · 01/03/2019

Abstract

Um regime de dosagem oral humana de G1T38 que fornece uma razão (AUC média (0-24),ss (h*ng/mL)) / (dose (mg)) inferior a 5 e/ou uma razão (AUC média (0-24),ss (h*ng/mL)) / (contagem absoluta de neutrófilos (células/mm3)) no dia 22 de término não superior a 1,25.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

04/07/2026

RPI 2883

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

12/01/2020

RPI 2604

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Related

Same category

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.